Author:
Nicaise C.,Ajani J.,Goudeau P.,Rozencweig M.,Levin B.,Krakoff I.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference8 articles.
1. Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH (1989) Comprehensive criteria for therapy-induced toxicity. Cancer Invest (in press)
2. Buroker RA, Comereski CR, Barnett AD, Hirth RS, Madissoo H, Hottendorf GH (1984) The toxicological evaluation of tallysomycin S10b biosynthetic tallysomycin derivative. Drug Chem Toxicol 7(3): 259–272
3. Comis RL (1978) Bleomycin pulmonary toxicity. In: Carter SK, Crooke ST (eds) Bleomycin. Current status and new developments, pp 279–291, Harcourt Brace Jovanovich, publisher Orlando
4. Crooke ST (1978) Bleomycin: a brief review. In: Carter SK, Crooke ST (eds) Bleomycin. Current status and new developments, pp 2–8, same as No. 3
5. Paolozzi FP, Gaver RC, Newman NB, Poiesz BJ, DeFino S, Lovie A, Conies RL (1989) Phase I trial of tallysomycin S10b, a bleomycin analogue. (in press) Invest New Drug
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献